A stringent dual control system overseeing transcription and activity of the Cre recombinase for the liver-specific conditional gene knock-out mouse model

https://doi.org/10.1016/S1673-8527(08)60060-0Get rights and content

Abstract

Liver cancer is one of the most threatening diseases in Chinese population. Just like in other tissues, tumor initiation and development in liver involve multiple steps of genetic and epigenetic alterations with several unknown details. However, unlike in other tissues, a tissue specific inducible Cre recombinase system that allows temporal and spatial deletion of a target DNA fragment is still not available for in vivo functional gene annotation in hepatocytes. In our pursuit to establish such a mouse model, we designed a dual inducible Cre transgene system and tested it in cultured cells. By combining a CCAAT/enhancer binding protein β (C/EBP β) promoter derived Tet-off expression system and the estrogen receptor (ER) mediated functional control, we show a desirable profile of both hepatocyte-specificity and regulability of the Cre expression in a series of critical assessments in the cell culture system, which provides confidence in continuation of our ongoing pursuit in mouse.

References (36)

  • G. Erdmann et al.

    Inducible gene inactivation in neurons of the adult mouse forebrain

    BMC Neurosci.

    (2007)
  • R. Feil et al.

    Ligand-activated site-specific recombination in mice

    Proc. Natl. Acad. Sci. USA.

    (1996)
  • A.P. Feinberg

    Phenotypic plasticity and the epigenetics of human disease

    Nature

    (2007)
  • K.K. Frese et al.

    Maximizing mouse cancer models

    Nat. Rev. Cancer

    (2007)
  • A.L. Garcia-Otin et al.

    Mammalian genome targeting using site-specific recombinases

    Front. Biosci.

    (2006)
  • S. Glaser et al.

    Current issues in mouse genome engineering

    Nat. Genet.

    (2005)
  • M. Gossen et al.

    Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

    Proc. Natl. Acad. Sci. USA.

    (1992)
  • P.G. Hirrlinger et al.

    Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2

    Glia

    (2006)
  • View full text